Germline BRCA1/2 mutations (gBRCAm) confer an increased risk of breast and HGSOC, and, to a lesser extent, of other type of cancers such as certain pancreatic [18], prostate [19], stomach and colon cancers [20]. This evidence concerns the gene BRCA1 and cancer.